T1	Participants 45 75	head and neck cancer patients.
T2	Participants 91 111	head and neck cancer
T3	Participants 678 734	patients undergoing treatment for head and neck cancers.
T4	Participants 1280 1336	patients undergoing treatment for head and neck cancers.
